京都大学大学院医学研究科 血液・腫瘍内科学

研究

ホーム研究 > 臨床研究グループ

臨床研究グループ

近藤 忠一(講師),菱澤 方勝(助教),諫田 淳也(助教),新井 康之(医員)
恩田 佳幸(研究員),渡邊 瑞希(大学院3年生)
大森 勝之(研究員),新堂 真紀(研究員),塩田 貞子(技術補佐員)
岡 恵(移植コーディネーター), 奥田 智子(CRC),古阪 絵美(CRC)

当研究室では全国あるいは関連病院との多施設共同臨床研究の企画・推進や,臨床関係のデーターベースの構築,臨床検体の集積・保存システムの構築,造血幹細胞移植の情報管理・研究を行っています。

多施設共同臨床研究のため,京都大学の関連病院による研究グループ KHSG(Kyoto Hematology Study Group)を立ち上げました。このグループにより2012年7月から開始した「再発又は難治性CD20陽性低悪性度B細胞性非ホジキンリンパ腫及びマントル細胞リンパ腫患者を対象にしたベンダムスチン,リツキシマブ併用療法の有効性と安全性の検討:臨床第II相試験」は症例登録が終了しました。現在は,「未治療移植適応多発性骨髄腫患者を対象にしたボルテゾミブを用いた寛解導入・地固め・維持療法および大量抗がん剤併用自家末梢血幹細胞移植の安全性と有効性の検討:臨床第II相試験」,「再発・難治性成人T細胞白血病に対するアバカビルの有効性および安全性に関する多施設共同治験」,「骨髄異形成症候群に対する同種造血幹細胞移植におけるアザシチジンの位置付けに関する多施設共同後方視的疫学研究」などに取り組んでいます。また,院内における単施設でのさまざまな研究にも取り組んでおります。2016年には関連病院と共同で造血幹細胞移植に関する研究グループKSCTG(Kyoto Stem Cell Transplantation Group)を新たに立ち上げました。臨床研究に関心のある大学院生,さらに医員として入局いただいた先生方には,臨床研究のプロジェクトに参加いただき,臨床研究に関する教育も行っております。今後もグループによる臨床研究を発展させていきたいと考えています。

当科で行っている臨床試験についてはこちらのページをご覧ください。

最近の業績(抜粋)

  • Yoshinaga , Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A.Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biol Blood Marrow Transplant. 2018, in press
  • Kamitori T, Umeda K, Tasaka K, Ogata H, Mikami T, Kato I, Hiramatsu H, Kondo T, and Adachi S. Chronic myeloid leukemia following treatment for bilateral retinoblastoma. Pediatric Blood & Cancer. 2018, in press.
  • Kawaguchi K, Umeda K, Hiejima E, Iwai A, Mikami M, Nodomi S, Saida S, Kato I, Hiramatsu H, Yasumi T, Nishikomori R, Kondo T, Takaori-Kondo A, Heike T, and Adachi S. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2018, in press.
  • Arai Y, Matsui H, Jo T, Kondo T, Takaori-Kondo A. Response to the comment by Cirasino L and Semeraro S. "Need to direct immune thrombocytopenia therapy towards shared goals" Direct and indirect comparisons to determine the first choice for newly diagnosed primary immune thrombocytopenia (ITP) in adults. Haematologica. 2018, in press.
  • Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, Mori T, Uoshima N, Nagafuji K, Yamasaki S, Shibasaki Y, Sakai R, Kato K, Choi I, Jo Y, Eto T, Kako S, Oshima K, Fukuda T. Effects of prophylactic foscarnet on HHV-6 reactivation and HHV-6 encephalitis in cord blood transplant recipients: a prospective multicenter cohort study with a historical control group. Biol Blood Marrow Transplant. 2018, in press
  • 濱田 涼太,吉田 路子,宮坂 淳介,南角 学,近藤 忠一,高折 晃史,池口 良輔,松田 秀一。同種造血幹細胞移植前の運動耐容能が移植後の身体機能に与える影響-移植前リハビリテーション介入の可能性 日本造血細胞移植学会誌. 2018, in press.
  • Yoshimura K, Yano I, Yamamoto T, Kondo T, Kawanishi M, Isomoto Y, Yonezawa A, Takaori-Kondo A, and Matsubara K. Pharmacokinetic and Pharmacodynamic Markers of Mycophenolic Acid Are Associated with Effective Prophylaxis for Acute Graft-versus-Host Disease and Neutrophil Engraftment in Cord Blood Transplant Patients.Biol Blood Marrow Transplant. 2018, in press
  • Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C. The efficacy and long-term outcomes of autologous stem cell transplantation in POEMS syndrome: A nationwide survey in Japan. Biol Blood Marrow Transplant. 2018, in press
  • Arima H, Fujimoto M, Nishikori1 M, Kitano T, Kishimoto W, Hishizawa M, Kondo T, Yamashita K, Hirata M, Haga H, Takaori-Kondo A. Prognostic impact of activation-induced cytidine deaminase expression for patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2017, in press.
  • Arai Y, Choi U, Corsino CI, Koontz SM, Tajima M, Sweeney CL, Black MA, Feldman SA, Dinauer MC, Malech HL. Myeloid conditioning with c-kit-targeted CAR-T cells enables donor stem cell engraftment. Mol Ther. 2018;26(5):1181-1197.
  • Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Biol Blood Marrow Transplant. 24(4): 717-725, 2018.
  • Yamazaki H, Kondo T, Aoki K, Yamashita K, Takaori-Kondo A. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with haematological disorders: A retrospective analysis. Diagn Microbiol Infect Dis. 90(2): 123-131, 2018.
  • Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Hidaka M, Kobayashi N, Iwato K, Sakura T, Onizuka M, Ozawa Y, Eto T, Kurokawa M, Kahata K, Uchida N, Atsuta Y, Mizuta S, and Kako S. Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. Am J Hematol. 93(1): 47-57, 2018.
  • Arai Y, Matsui H, Jo T, Kondo T, Takaori-Kondo A. Comparison of up-front treatments for newly diagnosed immunethrombocytopenia - a systematic review and network meta-analysis.Haematologica. 103(1): 163-171, 2018.
  • Kondo T. Significance of an intensified myeloablative conditioning regimen for myeloid malignancy and acute lymphoblastic leukemia. Journal of Hematopoietic cell transplantation. 7(1): 1-8, 2018.
  • Kawamura K, Kako S, Mizuta S, Ishiyama K, Aoki J, Yano S, Fukuda T, Uchida N, Ozawa Y, Eto T, Iwato K, Kanamor H, Kahata K,Kondo T, Sawa M, Ichinohe T, Atsuta Y, Kanda Y. Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplant Recipients 50 Years or Older. Biol Blood Marrow Transplant. 23(12): 2079-2087, 2017.
  • Yoshimura K, Yano I, Yamamoto T, Kawanishi M, Isomoto Y, Yonezawa A, Kondo T, Takaori-Kondo A, and Matsubara K. Population pharmacokinetics and pharmacodynamics of mycophenolic acid using prospective data in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 53(1): 44-51, 2018.
  • Hijiya K, Chen-Yoshikawa TF, Miyagawa-Hayashino A, Kondo T, Aoyama A, Haga H, Takaori-kondo A, Date H. Pulmonary endothelial chimerism after hematopoietic stem cell transplantation. Surg Today. 48(1): 101-109, 2018.
  • Tachibana T, Kanda J, Machida S, Saito T, Tanaka M, Najima Y, Koyama S, Miyazaki T, Yamamoto E, Takeuchi M, Morita S, Kanda Y, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302). Int J Hematol. 107(5):578-585, 2018.
  • Kameda K, Kako S, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Kanda J, Tanihara A, Wada H, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kanda Y. Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. Ann Hematol. 97(1):169-179, 2018.
  • Nakasone H, Terasako-Saito K, Hirano T, Wake A, Shimizu S, Kurita N, Yamazaki E, Usuki K, Akazawa K, Kanda J, Minauchi K, Yamamoto G, Tanimoto S, Kamoshita M, Yokoyama Y, Miyaoka E, Ota S, Kako S, Izutsu K, Kanda Y. Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematol Oncol 36(1):202-209, 2018.
  • Kataoka K, Iwanaga M, Yasunaga JI, Nagata Y, Kitanaka A, Kameda T, Yoshimitsu M, Shiraishi Y, Sato-Otsubo A, Sanada M, Chiba K, Tanaka H, Ochi Y, Aoki K, Suzuki H, Shiozawa Y, Yoshizato T, Sato Y, Yoshida K, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Shide K, Kubuki Y, Hidaka T, Nakamaki T, Ishiyama K, Miyawaki S, Ishii R, Nureki O, Tobinai K, Miyazaki Y, Takaori-Kondo A, Shibata T, Miyano S, Ishitsuka K, Utsunomiya A, Shimoda K, Matsuoka M, Watanabe T, Ogawa S. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. Blood. 131(2): 215-225, 2018
  • Onishi Y, Mori T, Kako S, Koh H, Uchida N, Kondo T, Kobayashi T, Yabe H, Miyamoto T, Kato K, Suzuki R, Nakao S, Yamazaki H. Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biol Blood Marrow Transplant. 23(12): 2137-2142, 2017.
  • Wada H, Kanda J, Akahoshi Y, Nakano H, Ugai T, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Tanihara A, Nishida J, Kanda Y. Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. Hematology. 2017 in press.
  • Kameda K, Nakasone H, Komiya Y, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Tamaki M, Harada N, Kusuda M, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Tanihara A, Wada H, Terasako-Saito K, Kikuchi M, Kimura SI, Kako S, Kanda Y. Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. Biol Blood Marrow Transplant. 23(11):1895-1902, 2017.
  • Kanda J . Impact of HLA mismatch on transplant outcomes. [Article in Japanese] Rinsho Ketsueki.58(12):2415-2424, 2017.
  • Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation. Leukemia. 31(3):663-668, 2017.
  • Yui S, Kurosawa S, Yamaguchi H, Kanamori H, Ueki T, Uoshima N, Mizuno I, Shono K, Usuki K, Chiba S, Nakamura Y, Yanada M, Kanda J, Tajika K, Gomi S, Fukunaga K, Wakita S, Ryotokuji T, Fukuda T, Inokuchi K. D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations. Ann Hematol. 96(10):1641-1652, 2017.
  • Kawamura K, Kanda J, Fuji S, Murata M, Ikegame K, Yoshioka K, Fukuda T, Ozawa Y, Uchida N, Iwato K, Sakura T, Hidaka M, Hashimoto H, Ichinohe T, Atsuta Y, Kanda Y. Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation. Bone Marrow Transplant. 52(10):1390-1398, 2017.
  • Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T. GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia. Bone Marrow Transplant. 52(9):1261-1267, 2017.
  • Akahoshi Y, Kanda J, Ohno A, Komiya Y, Gomyo A, Hayakawa J, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Shiraki K, Kanda Y. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. J Infect Chemother. 23(7):485-487, 2017.
  • Yamasaki R, Kanda J, Akahoshi Y, Nakano H, Ugai T, Wada H, Kawamura K, Ishihara Y, Sakamoto K, Sato M, Ashizawa M, Machishima T, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Kanda Y. Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia. Int J Hematol. 05(6):835-840, 2017.
  • Hayakawa J, Kanda J, Akahoshi Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Yamazaki R, Kako S, Kanda Y. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. Int J Hematol. 105(5):578-586, 2017.
  • Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kitano T, Kondo T, Hishizawa M, Tomosugi N, Takaori-Kondo A. High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation. Cancer Med. 6(1):120-128, 2017.
  • Yokoyama H, Kanda J, Fuji S, Kim SW, Fukuda T, Najima Y, Ohno H, Uchida N, Ueda Y, Eto T, Iwato K, Kobayashi H, Ozawa Y, Kondo T, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen. Biol Blood Marrow Transplant. 23(2):300-309, 2017.
  • Mori T, Kanda Y, Takenaka K, Okamoto S, Kato J, Kanda J, Yoshimoto G, Gondo H, Doi S, Inaba M, Kodera Y. Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial. Int J Hematol. 105(2):206-212, 2017.
  • Jo T, Arai Y, Kondo T, Kitano T, Hishizawa M, Yamashita K, Takaori-Kondo A. Chronic kidney disease in long-term survivors after allogeneic hematopoietic stem cell transplantation: retrospective analysis at a single institute. Biol Blood Marrow Transplant. 23(12): 2159-2165, 2017.
  • Ogata M, Oshima K, Ikebe T, Takano K, Kanamori H, Kondo T, Ueda Y, Mori T, Hashimoto H, Ogawa H, Eto T, Ueki T, Miyamoto T, Ichinohe T, Atsuta Y,and Fukuda T. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 52(11): 1563-1570, 2017.
  • Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S and Atsuta Y. Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 23(10): 1749-1758, 2017.
  • Arai Y, Matsui H, Jo T, Kondo T, Takaori-Kondo A. Efficacy of dexamethasone for acute primary immune thrombocytopenia compared to prednisolone - a systematic review and meta-analysis. Thromb Hemostat Open. 1(2)e73-81, 2017.
  • Tomizawa D, Tanaka S, Kondo T, Hashii Y, Arai Y, Kudo K, Taga T, Fukuda T, Goto H, Inagaki J, Koh K, Ohashi K, Ozawa Y, Inoue M, Kato K, Tanaka J, Atsuta Y, Adachi S, Ishida H. Allogeneic hematopoietic stem cell transplantation for adolescents and young adults with acute myeloid leukemia. Biol Blood Marrow Transplant. 23(9): 1515-1522, 2017.
  • Oka T, Kobayashi M, Komori T, Nakamine H, Kitano T, Hishizawa M, Kondo T, Yamashita K, Takaori-Kondo A. Follicular lymphoma with plasmacytic differentiation accompanied by monoclonal IgG gammopathy. Rinsho Ketsueki. 58(6): 595-600, 2017.
  • Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, and Mizuta S on behalf of the Japan Society for Hematopoietic Cell Transplantation. Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukemia in adults.Br J Haematol. 178(1): 106-111, 2017.
  • Konuma T, Kondo T, Yamashita T, Uchida N, Fukuda T, Ozawa Y, Ohashi K, Ogawa H, Kato C, Takahashi S, Kanamori H, Eto T, Nakaseko C, Kohno A, Ichinohe T, Atsuta Y, Takami A, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8. Ann Hematol. 96(3): 469-478, 2017.
  • Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia.Ann Hematol.96(2): 289-297, 2017 .
  • Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y,Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Outcomes of allogeneic hematopoietic stem cell transplantation in adult patients with myelodysplastic syndrome harboring trisomy 8. Biol Blood Marrow Transplant.23(1): 75-80, 2017.
  • Fujita M, Kawabata H, Oka T,Hishizawa M, Kitano T, Kondo T, Yamashita K, Yurugi K, Hirai H, Maekawa T, Takaori-Kondo A. A rare case of adult primary autoimmune neutropenia successfully treated with prednisolone. Intern Med. 56(11): 1415-1419, 2017.
  • Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, Kurokawa M, Arai S and Akashi K. Clinical features and outcomes of patients with primary myelofibrosis in Japan:Report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. Int J Hematol.105(1): 59-69, 2017.
  • Ishii A, Kondo T, Oka T, Nakamoto Y and Takaori-Kondo A. Granulocytic sarcoma of the pancreas on 18F-FDG PET/CT. A case report. Medicine(Baltimore). 95(49): e5570, 2016.
  • Arai Y, Kondo T, Shigematsu A, Tanaka J, Takahashi S, Kobayashi T, Uchida N,Onishi Y, Ishikawa J, Kanamori H, Sawa M, Yokota A, Kouzai Y, Takanashi M, Ichinohe T, Atsuta Y, and Mizuta S on behalf of the Japan Society for Hematopoietic Cell Transplantation. High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study. Bone Marrow Transplant. 51(12): 1636-1639, 2016.
  • Hirabayashi S, Kondo T, Oka T, Akamatsu Y,Hishizawa M, Shibata T,Kitano T and Takaori-Kondo A. Successful treatment of severe acute gastrointestinal graft-versus-host disease complicated by cytomegalovirus gastroenteritis with intra-arterial steroid infusion. Ann Hematol. 95(8): 1373-1375, 2016.
  • Kitanaka A, Takenaka K, Shide K, Miyamoto T, Kondo T, Ozawa K, Kurokawa M, Akashi K and Shimoda K. Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients. Int J Hematol. 103(4): 423-8, 2016.
  • Sakurada M, Kondo T, Umeda M, Kawabata H, Yamashita K, and Akifum Takaori-Kondo A. Successful treatment with intravesical cidofovir for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A case report and a review of the literature. J Infect Chemother. 22(7): 495-500, 2016.
  • Kato M, Yamashita T, Suzuki R, Matsumoto K, Nishimori H, Takahashi S, Iwato K, Nakaseko C, Kondo T, Imada K, Kimura F, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Taniguchi S, and Fukuda T. Donor cell-derived hematologic malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation. Leukemia. 30(8): 1742-5, 2016.
  • Nishikori M, Kitawaki T, Tashima M, Shimazu Y, Mori M, Hishizawa M, Kondo T, Ohmori K, Takaori-Kondo A. Diminished CD2 expression in T cells permits tumor immune escape. Journal of Clinical and Cellular Immunology.7: 406, 2016.
  • Aoki J, Seo S, Kanamori H, Tanaka M, Fukuda T, Onizuka M, Kobayashi N, Kondo T, Sawa M, Uchida N, Iwato K, Icihnohe T, Atsuta Y, Yano S and Takami A. Impact of low-dose total body irradiation on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Bone Marrow Transplant. 51(4): 604-6, 2016.
  • Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y,Fukuda, T, Hidaka M, Moriuchi Y, Miyamoto T, Uike N, Taguchi J, Eto T, Tomoyose T, Kondo T, Yamanoha A, Ichinohe T, Atsuta Y, Utsunomiya A. Early application of related stem-cell transplantation might improve clinical outcome in adult T-cell leukemia/lymphoma.Bone Marrow Transplant. 51(2): 205-11, 2016 .
  • Arai Y, Kanda J, Nakasone H,Kondo T, Uchida N, Fukuda T, Ohashi, Kaida, K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, and Murata M. Bone Marrow Transplant. 51(1):96-102, 2016.
  • Ishiyama K, Takeda J, Kondo T, Sugimoto N, Kawabata H, Kitano T and Akifumi Takaori-Kondo. Feasibility of salvage cord blood transplantation following fludarabine, melphalan, and low-dose TBI for graft rejection after hematopoietic stem cell transplantation. Bone Marrow Transplant. 51(7): 985-7, 2016.
  • Arai Y, Kondo T, Yamazaki H, Takenaka K, Sugita J, Kobayashi T, Ozawa Y, Uchida N, Iwato K, Kobayashi N, Takahashi Y, Ishiyama K, Fukua T, Ichinohe T, Atsuta Y, Mori T and Teshima T on behalf of the Japan Society for Hematopoietic Cell Transplantation. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia. Haematologica. 101(5): 644-52, 2016.
  • Yamazaki H, Aoki K, Kondo T, Nishikori M, Kitano T, Hishizawa M, Yamashita K, Takaori-Kondo A. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Cases of Mature T/NK-Cell Neoplasms: A Single-center Retrospective Analysis. Ann Hematol. 96(2): 323-326, 2016.
  • Arai Y, Jo T, Matsui H, Kondo T and Takaori-Kondo A. Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation - a systematic review and meta-analysis. Leuk Lymphoma. 58(8): 1840-1848, 2016.
  • Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T; JSHCT GVHD Working Group. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. Haematologica. 2016 Dec;101(12):1592-1602.
  • Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, Ohashi K, Ishikawa J, Ogawa H, Inoue M, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes. Biol Blood Marrow Transplant. 2016 Nov;22(11):2031-2037.
  • Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y; Japan Society for Hematopoietic Cell Transplantation. A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia. Biol Blood Marrow Transplant. 2016 Oct;22(10):1836-43.
  • Akahoshi Y, Kanda J, Gomyo A, Hayakawa J, Komiya Y, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda Y. Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Sep;22(9):1678-83.
  • Teramura Y, Kameda K, Kanda J, Gomyo A, Hayakawa J, Akahoshi Y, Komiya Y, Harada N, Ugai T, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Wada H, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Kako S, Kanda Y. Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma. Rinsho Ketsueki. 2016 May;57(5):597-601.
  • Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S, Kanamori H, Hidaka M, Sakura T, Onizuka M, Kobayashi N, Sawa M, Eto T, Matsuhashi Y, Kato K, Ichinohe T, Atsuta Y, Miyamura K; Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. Am J Hematol. 2016 May;91(5):E284-92.
  • Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W. Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. Biol Blood Marrow Transplant. 2016 Apr;22(4):744-51.
  • Yanada M, Kanda J, Ohtake S, Fukuda T, Sakamaki H, Miyamura K, Miyawaki S, Uchida N, Maeda T, Nagamura-Inoue T, Asou N, Morishima Y, Atsuta Y, Miyazaki Y, Kimura F, Kobayashi Y, Takami A, Naoe T, Kanda Y. Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission. Eur J Haematol. 2016 Sep;97(3):278-87.
  • Kanda J . Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation. Int J Hematol. 2016 Jan;103(1):11-9.
  • Shimazu Y, Shimazu Y, Hishizawa M, Hamaguchi M, Nagai Y, Sugino N, Fujii S, Kawahara M, Kadowaki N, Nishikawa H, Sakaguchi S, Takaori-Kondo A. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia. Cancer Immunol Res. 4(2):136-45, 2016
  • Nishikori M, Kitano T, Kobayashi M, Hishizawa M, Kitawaki T, Kondo T, Yamashita K, Kawabata H, Kadowaki N, Takei Y, Haga H, Takaori-Kondo A. Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine. Int J Hematol. 102(1): 53-8, 2015.
  • Arai Y, Takeda J, Aoki K, Kondo T, Takahashi S, Onishi Y, Ozawa Y, Aotsuka N, Kouzai Y, Nakamae H, Ota S, Nakaseko C, Yamaguchi H, Kato K, Atsuta Y, Takami A; AML and MDS Working Group of the Japan Society for Hematopoietic Cell Transplantation. Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. Blood. 2015 Jul 16;126(3):415-22.
  • Aoki T, Suzuki R, Kuwatsuka Y, Kako S, Fujimoto K, Taguchi J, Kondo T, Ohata K, Ito T, Kamoda Y, Fukuda T, Ichinohe T, Takeuchi K, Izutsu K, Suzumiya J. Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm: A retrospective registry study from the Japan Society for Hematopoietic Cell Transplantation. Blood. 125(23): 3559-62, 2015.
  • Arai Y, Kondo T, Kitano T, Hishizawa M, Yamashita K, Kadowaki N, Yamamoto T, Yano I, Matsubara K, Takaori-Kondo A. Monitoring mycophenol ate mofetil is necessary for the effective prophylaxis of acute graft versus host disease after cord blood transplantation. Bone Marrow Transplant. 50(2): 312-4, 2015
  • Arai Y, Aoki K, Takeda J, Kondo T, Eto T, Ota S, Hashimoto H, Fukuda T, Ozawa Y, Kanda Y, Kato C, Kurokawa M, Iwato K, Onizuka M, Ichinohe T, Atsuta Y and Takami A. Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy. J Hematol and Oncol. 4;8;102, 2015.
  • Nagai Y, Kawahara M, Hishizawa M, Shimazu Y, Sugino N, Fujii S, Kadowaki N, Takaori-Kondo A. T memory stem cells are the hierarchical apex of adult T-cell leukemia.Blood. 125(23):3527-35, 2015
  • Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, Totoki Y, Chiba K, Sato-Otsubo A, Nagae G, Ishii R, Muto S, Kotani S, Watatani Y, Takeda J, Sanada M, Tanaka H, Suzuki H, Sato Y, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Iwanaga M, Ma G, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Ogasawara H, Sato T, Sasai K, Muramoto K, Penova M, Kawaguchi T, Nakamura H, Hama N, Shide K, Kubuki Y, Hidaka T, Kameda T, Nakamaki T, Ishiyama K, Miyawaki S, Yoon SS, Tobinai K, Miyazaki Y, Takaori-Kondo A, Matsuda F, Takeuchi K, Nureki O, Aburatani H, Watanabe T, Shibata T, Matsuoka M, Miyano S, Shimoda K, Ogawa S. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 47(11):1304-15, 2015.
  • Honda T, Hishizawa M, Kataoka TR, Ohmori K, Takaori-Kondo A, Miyachi Y, Kabashima K. Stevens-Johnson Syndrome Associated with Mogamulizumab-induced Deficiency of Regulatory T cells in an Adult T-cell Leukaemia Patient. Acta Derm Venereol. 95(5):606-7, 2015